These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26051660)

  • 1. [Ablative treatments in localized renal cancer: literature review for 2014].
    Chodez M; Fiard G; Arnoux V; Descotes JL; Long JA
    Prog Urol; 2015 Jul; 25(9):499-509. PubMed ID: 26051660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ablative therapy in kidney cancer: Oncological, functional, perioperative outcomes and cost].
    Mouracade P; Tricard T; Gangi A; Cathelineau X; Lang H
    Prog Urol; 2017 Nov; 27(15):952-970. PubMed ID: 28890005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ablative therapy in kidney cancer: Indications].
    Tricard T; Tsoumakidou G; Lindner V; Garnon J; Albrand G; Cathelineau X; Gangi A; Lang H
    Prog Urol; 2017 Nov; 27(15):926-951. PubMed ID: 28869173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
    Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
    Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for ablative treatment in kidney cancer in the elderly].
    Froger L; Neuzillet Y; Lebret T
    Prog Urol; 2012 Dec; 22(16):1004-9. PubMed ID: 23178096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablative Therapy for Small Renal Masses.
    Taylor BL; Stavropoulos SW; Guzzo TJ
    Urol Clin North Am; 2017 May; 44(2):223-231. PubMed ID: 28411914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cryotherapy percutaneous for renal tumors: Our center's beginning experience].
    Lalloué F; Ruffion A; Valette PJ; Crouzet S; Martin X; Rouvière O; Paparel P
    Prog Urol; 2016 Apr; 26(5):310-8. PubMed ID: 27032313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary management of small renal masses.
    Volpe A; Cadeddu JA; Cestari A; Gill IS; Jewett MA; Joniau S; Kirkali Z; Marberger M; Patard JJ; Staehler M; Uzzo RG
    Eur Urol; 2011 Sep; 60(3):501-15. PubMed ID: 21664040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablative Therapies for Renal Tumors: Patient Selection, Treatment Planning, and Follow-Up.
    Correas JM; Delavaud C; Gregory J; Le Guilchet T; Lamhaut L; Timsit MO; Méjean A; Hélénon O
    Semin Ultrasound CT MR; 2017 Feb; 38(1):78-95. PubMed ID: 28237283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal ablative therapies for treatment of localised renal cell carcinoma: a systematic review of the literature.
    Gkentzis A; Oades G
    Scott Med J; 2016 Nov; 61(4):185-191. PubMed ID: 27247133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis.
    Hu X; Shao YX; Wang Y; Yang ZQ; Yang WX; Li X
    Eur J Surg Oncol; 2019 Sep; 45(9):1527-1535. PubMed ID: 31171480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
    Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
    Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage surgery after energy ablation for renal masses.
    Karam JA; Wood CG; Compton ZR; Rao P; Vikram R; Ahrar K; Matin SF
    BJU Int; 2015 Jan; 115(1):74-80. PubMed ID: 24656119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.
    Farrag K; Sriprasad S
    Indian J Surg Oncol; 2017 Mar; 8(1):39-45. PubMed ID: 28127181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of laparoscopic surgery for renal masses: prevention, management, and comparison with the open experience.
    Breda A; Finelli A; Janetschek G; Porpiglia F; Montorsi F
    Eur Urol; 2009 Apr; 55(4):836-50. PubMed ID: 19168276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous renal ablation: Pre-, per-, post-interventional evaluation modalities and adapted management].
    Garnon J; Tricard T; Cazzato RL; Cathelineau X; Gangi A; Lang H
    Prog Urol; 2017 Nov; 27(15):971-993. PubMed ID: 28942001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablative therapies in renal cell carcinoma.
    Chan AA; Ahrar K; Matin SF
    Minerva Urol Nefrol; 2011 Sep; 63(3):237-50. PubMed ID: 21993322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiofrequency ablation of renal cell carcinoma].
    Estébanez Zarranz J; Artozki Morras E; Aguirreazaldegui García L; Crespo Crespo I; Bandrés Iruretagoyena F; Sanz Jaka JP
    Actas Urol Esp; 2009 Jan; 33(1):35-42. PubMed ID: 19462723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
    Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
    Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.